RecruitingNot applicableNCT06523374

A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer

Studying Carcinoma of esophagus

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Antwerp
Principal Investigator
Sheila Krishnadath
Universitair Ziekenhuis Antwerpen (UZA)
Intervention
Endoscopic brush cytology(procedure)
Enrollment
50 target
Eligibility
18 years · All sexes
Timeline
2025 – 2027

Study locations (9)

Collaborators

Karolinska Institutet · Universal Diagnostics · Amsterdam UMC · Radboud University Medical Center · AZ Delta · University of Leipzig · IRCCS Ospedale San Raffaele · Karolinska University Hospital · University of Dublin, Trinity College · Heinrich-Heine University, Duesseldorf · GZA Ziekenhuizen Campus Sint-Augustinus · University Hospital, Ghent · Rigshospitalet, Denmark · Universitätsklinikum Leipzig · St. James's Hospital, Ireland · University Hospital, Lille

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06523374 on ClinicalTrials.gov

Other trials for Carcinoma of esophagus

Additional recruiting or active studies for the same condition.

See all trials for Carcinoma of esophagus →

← Back to all trials